Edward M. Kaye MD
Director · 9 filings · Latest: Aug 14, 2026
Avidity Biosciences, Inc.
CYTOKINETICS INC
Stoke Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
STOK | Edward M. Kaye MD | Director | Aug 18, 2026 | Sale | $32.03 | 12,567 | $402.5K | 124,557 | |
STOK | Edward M. Kaye MD | Director | Aug 14, 2026 | Option Exercise | $0.00 | 26,250 | — | 137,124 | |
CYTK | Edward M. Kaye MD | Director | Jun 1, 2026 | Sale | $76.09 | 2,933 | $223.2K | 10,283 | |
CYTK | EDWARD KAYE | — | Jun 1, 2026 | Proposed Sale | $76.76 | 2,933 | $225.1K | — | |
STOK | Edward M. Kaye MD | Director | Mar 15, 2026 | Option Exercise | $0.00 | 61,750 | — | 110,874 | |
STOK | EDWARD M KAYE | — | Dec 8, 2025 | Proposed Sale | $30.87 | 13,430 | $414.6K | — | |
STOK | EDWARD M KAYE | — | Dec 5, 2025 | Proposed Sale | $31.05 | 2,181 | $67.7K | — | |
CYTK | EDWARD KAYE | — | Dec 1, 2025 | Proposed Sale | $68.13 | 28,064 | $1.9M | — | |
CYTK | EDWARD KAYE | — | Nov 11, 2025 | Proposed Sale | $62.20 | 5,175 | $321.9K | — | |
STOK | EDWARD M KAYE | — | Oct 8, 2025 | Proposed Sale | $27.31 | 25,000 | $682.8K | — | |
CYTK | EDWARD KAYE | — | Oct 6, 2025 | Proposed Sale | $56.97 | 6,757 | $384.9K | — | |
STOK | EDWARD M KAYE | — | Oct 3, 2025 | Proposed Sale | $24.82 | 42,461 | $1.1M | — | |
CYTK | EDWARD KAYE | — | Sep 30, 2025 | Proposed Sale | $53.89 | 6,695 | $360.8K | — | |
CYTK | EDWARD KAYE | — | Sep 2, 2025 | Proposed Sale | $35.33 | 6,756 | $238.7K | — | |
STOK | EDWARD M KAYE | — | Aug 29, 2025 | Proposed Sale | $19.77 | 61,885 | $1.2M | — | |
CYTK | EDWARD KAYE | — | Jun 5, 2025 | Proposed Sale | $32.41 | 3,636 | $117.8K | — |